Five Oceans Advisors Astrazeneca PLC Transaction History
Five Oceans Advisors
- $205 Million
- Q2 2025
A detailed history of Five Oceans Advisors transactions in Astrazeneca PLC stock. As of the latest transaction made, Five Oceans Advisors holds 7,592 shares of AZN stock, worth $558,391. This represents 0.26% of its overall portfolio holdings.
Number of Shares
7,592
Previous 7,591
0.01%
Holding current value
$558,391
Previous $557,000
4.85%
% of portfolio
0.26%
Previous 0.3%
Shares
11 transactions
Others Institutions Holding AZN
# of Institutions
1,421Shares Held
508MCall Options Held
9.82MPut Options Held
3.14M-
Price T Rowe Associates Inc Baltimore, MD57.1MShares$4.2 Billion0.52% of portfolio
-
Primecap Management CO Pasadena, CA40.7MShares$2.99 Billion2.53% of portfolio
-
Wellington Management Group LLP Boston, MA35.6MShares$2.62 Billion0.52% of portfolio
-
Bank Of America Corp Charlotte, NC31.8MShares$2.34 Billion0.19% of portfolio
-
Capital International Investors Los Angeles, CA31.3MShares$2.3 Billion0.47% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $228B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...